tbuckley/cabot-search huggingface dataset:
Corrections
Authors: D.-B Ardill, R Dowling, J Ferris, A Mcdevitt, B Scott, M Malik, -2g Soyannwo, B Cole, -S Allen, J Boucher, S Fenton, R Finch, Shirley Hanoman-Singh, D Hoey, Davinder Kapur, J Mccully, Eleanor Patterson, A Protos, B Rooney, K Sherlock, T Smyth, -N Baldock, N Coward, P Densham, J Dodoo, A Dosumu, A Fishtal, P Garner, J Hammond-Evans, R Maraj, R Parks, N Smith, G Steer, R Teague, Julia Santen, J Witcher, Hedley Atkins, R Merle D'aubign6, D Easty, N Kay, C Young, D Worgan, A Driscoll, J Agbim, J Brown, A Bennett, J Gilchrist, J Thomson, J Gumpert, A Fenton, P Amery, D Morrison, J Robinson, M Booth, R Briggs, A Marsh, ) Robson, M Fife, S Jennings, C Powis, J Banks, A Nicholls, G Dowlatad, D Welply, G Whittam, K 6lazer, J Reynolds, D Bourke, D Dandy, E Ingram, M Berkeley, El El Maguid, J Mistikawy, A Jackson, A Khaliq, Abdel-Aziz Abdel-Mottalib, D Kleinig, H O'donoghue, D Ghosh, A Nada, S Paul, C Troy, A Hempel, T Maung, Kumar Mohan, A El-Mariah, P Perdikis, M Zutshi, K Rao, P Chakrabarty, N Datta, . Hanna, C Martin, W Paley
Journal: BMJ (1969)
Developmental Neurotoxicity of Chlorpyrifos Modeled in Vitro: Comparative Effects of Metabolites and Other Cholinesterase Inhibitors on DNA Synthesis in PC12 and C6 Cells
Authors: Dan Qiao, Frederic J. Seidler, Theodore A. Slotkin
Journal: Environmental Health Perspectives (2001)

The widely used organophosphate pesticide chlorpyrifos is a suspected neuroteratogen. In the current study, we compared the effects of chlorpyrifos and its major metabolites in two in vitro models, neuronotypic PC12 cells and gliotypic C6 cells. Chlorpyrifos inhibited DNA synthesis in both cell lines but had a greater effect on gliotypic cells. Chlorpyrifos oxon, the active metabolite that inhibits cholinesterase, also decreased DNA synthesis in PC12 and C6 cells with a preferential effect on the latter. Trichloropyridinol, the major catabolic product of chlorpyrifos, had a much smaller, but nevertheless statistically significant, effect that was equivalent in both cell lines. Diazinon, another organophosphate pesticide, also inhibited DNA synthesis with preference toward C6 cells, but was less effective than was chlorpyrifos. Physostigmine, a non-organophosphate cholinesterase inhibitor, was less effective than either chlorpyrifos or diazinon, but still caused significant inhibition of DNA synthesis in C6 cells. We also found that the addition of sera protected the cells from the adverse effects of chlorpyrifos and that the effect could be reproduced by addition of albumin. These results indicate that chlorpyrifos and other organophosphates such as diazinon have immediate, direct effects on neural cell replication, preferentially for gliotypic cells. In light of the protective effect of serum proteins, the fact that the fetus and newborn possess lower concentrations of these proteins suggests that greater neurotoxic effects may occur at blood levels of chlorpyrifos that are nontoxic to adults.
Abstract 4203: Diastolic Wall Strain Can Noninvasively Predict Hemodynamic Deterioration Unassociated with Systolic Dysfunction in Hypertensive Hearts
Authors: Yosuke Omori, Yasushi Sakata, Toshiaki Mano, Tomohito Ohtani, Yasuharu Takeda, Daisuke Kamimura, Shunsuke Tamaki, Kazuhiro Yamamoto
Journal: Circulation (2008)

This study examined whether LV diastolic wall strain (DWS) could noninvasively predict the transition to decompensated diastolic heart failure (DHF) in hypertensive hearts. Dahl salt-sensitive rats fed 0.3 % NaCl diet served as control group (group N: n=8) and those fed 8 % NaCl diet as hypertensive group (group HT: n=15). Serial Doppler echocardiographic studies were performed at age 13, 17 and 19 weeks. At 19 weeks, LV pressure was measured following the echocardiographic study. DWS was calculated as [(end-systolic thickness of LV posterior wall) - (end-diastolic thickness of LV posterior wall)]/(end-systolic thickness of LV posterior wall). Mid-wall fractional shortening (MFS) was not different between two groups at any stage. At 13 weeks (compensatory hypertrophic stage), the transmitral flow velocity curves (TMFV) represented the abnormal relaxation pattern with low E/A ratio in group HT. At 19 weeks (heart failure stage), E/A increased with the elevation of LV end-diastolic pressure and lung weight in group HT. DWS was not different between two groups at 13 weeks, however, its decrease preceded the pseudonormalization of TMFV at 17 weeks in group HT and continued until 19 weeks. The difference between the endocardial and epicardial movements is equal to that between the wall thickness at end-systole and end-diastole (a numerator of DWS). Therefore, based on the linear elastic theory, DWS is considered to decrease with increase of LV wall stiffness. We previously demonstrated that myocardial stiffness constant was elevated at age 17 weeks but not at age 13 weeks in Dahl salt-sensitive rats fed high-salt diet. The current results indicate that DWS is helpful in noninvasively predicting hemodynamic deterioration without the changes in systolic function, which is explained partly by the theory that DWS reflects LV wall stiffness. Echocardiographic Parameters and Hemodynamic Data in Control Group and Hypertensive Group
Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 2. Hemodynamic and drug disposition studies
Authors: R Mastai
Journal: Hepatology (1996)

We assessed hepatic functions and systemic and splanchnic hemodynamics in a new model of hepatic sinusoidal fibrosis. Fibrosis was induced by the simultaneous administration for 8 weeks of diethyl-stilbestrol (DES) (10 mg twice weekly, subcutaneously) and cholesterol-supplemented diet (1%) in rabbits. A marked and progressive impairment of hepatic function was observed during the 8 weeks of treatment with a significant decrease in indocyanine green (ICG) systemic clearance (- 89%; P < .001) and aminopyrine elimination (-69%; P < .001). In fibrotic animals, hyperdynamic circulation was found with an increased cardiac output (+73%, P < 0.01) and a decreased peripheral vascular resistance (-50%; P < .005), as evaluated by the microsphere technique in animals that were awake. The total portal venous inflow was not significantly modified in fibrotic rabbits. However, since there was a marked increase in the liver weight, the portal venous inflow was significantly decreased when expressed per gram of liver weight (-30%; P < .05). In contrast, the hepatic artery blood flow was markedly increased, even when expressed per gram of liver weight (+95%; P < .01). Portal pressure was significantly increased in treated rabbits (from 7.4 ± .4 to 14.4 ± .6 mm Hg, P < .01). This new experimental model could prove useful to evaluate the influence of extensive perisinusoidal fibrosis on exchanges between plasma and hepatocytes, particularly of protein-bound substances.
A sex difference in the prevalence of antibodies to cytomegalovirus
Authors: J. P. Luby
Journal: JAMA (1972)

Complement fixation antibodies to cytomegalovirus (CMV) were determined for 195 nonwhite persons residing in a circumscribed community in Dallas. Complement fixation antibody titers ≥ 1:8 were encountered in 45.1% of the sample. There was a progressive increase in CMV antibody prevalence with age. In each age group studied and particularly during the child-bearing years (15 to 44), the prevalence of CMV antibody was greater in women. Overall, CMV antibody rates for women (55.0%) differed significantly from those found for men (32.6%) (P&lt;.005).
Breath Hunger
Authors: Judith Skillman
Journal: JAMA (2006)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Current oxygen prescribing practices. Problems and prospects
Authors: M. S. Skorodin
Journal: JAMA (1986)

REGULATIONS and prescribing practices dealing with long-term home and ambulatory oxygen supplementation for patients with chronic lung disease are currently in a state of flux. Clearly, the move is on to limit this modality as much as possible because of its great expense. <h3>Changes in Oxygen Reimbursement Policy</h3> As recently as March 1985, Petty<sup>1</sup>recommended the following patient selection criteria: (1) stable clinical state with optimum medical therapy, eg, bronchodilator, antibiotics, corticosteroids (if indicated), and freedom from exacerbations of bronchitis or heart failure; (2) arterial blood gas analysis conducted on at least two occasions with the subject breathing room air for at least 20 minutes; (3) room-air arterial oxygen pressure (Pao<sub>2</sub>) consistently (three weeks or more) less than 55 mg Hg or consistently 55 to 59 mm Hg with clinical diagnosis of cor pulmonale, a hematocrit exceeding 55%, or both (entry criteria for the Nocturnal Oxygen Therapy Trial
THE STATUE OF DR. J. MARION SIMS IN BRYANT PARK.
Journal: JAMA (1894)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Neurology, Minneapolis
Journal: JAMA (1962)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Healthy Cities: Toward Worldwide Health Promotion
Authors: B. C. Flynn
Journal: Annual Review of Public Health (1996)

Healthy Cities is a community problem-solving process for health promotion that began in Canada and Europe in the mid-1980s. Although Healthy Cities have expanded worldwide, there is limited scientific literature that documents the effects of these efforts. This review describes the dynamic status of Healthy Cities globally and summarizes what is known about these efforts. It is difficult to draw generalizations or clear differences between Healthy Cities and other efforts with similar objectives in the United States. There appears to be less variation among Healthy Cities in Europe, most likely because of the extensive technical support provided by the WHO European Regional Office to the Healthy Cities Project. Case descriptions present the diversity and types of activities of Healthy Cities. It is concluded that community participation and broad involvement from different sectors of the community are promising approaches to addressing urban problems.
NATURAL AND ARTIFICIAL ANTHRAX IMMUNITY.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Royal College of Physicians: Report of the Committee on Chronic Rheumatic Diseases
Journal: Annals of the Rheumatic Diseases (1951)

The Committee appointed in 1950 has met on five occasions, and the following report was passed by the Fellows of the College at the Comitia on July 26, 1951.Definition.-A precise definition of the chronic rheumatic diseases is difficult, but for practical purposes the field under consideration should include rheumatoid arthritis, osteo-arthritis, spondylitis, gout, and the various forms of non-articular rheumatism, together with the differential diagnosis of these from other conditions which may simulate them.Introduction.-Thesediseases are of great importance for economic reasons owing to the large number of man-hours they cause to be lost each year, and equally for humanitarian and medical reasons because of the extent to which they cripple the patient and disrupt family life.Until recently, however, they have received scant attention in the way of organized treatment, teaching, or research.Early specialization in this field, and the excessive multiplication of posts devoted exclusively to chronic rheumatic diseases leading to further unnecessary fragmentation of general medicine are to be deprecated.However, within the scope of general medicine, the importance of this group of diseases deserves greater recognition for their effective control.In this connection, gastro- enterology, cardiology, and neurology may be cited as examples of branches of medicine requiring varying degrees of special training, yet remaining as part of general medicine.Thus the chronic rheumatic diseases should not generally be a whole-time specialty, but should constitute a special interest within general medicine; alternatively, after appropriate training in general medicine, this specialty could be combined with physical medicine or orthopaedics.Study in this field should not be allowed to become an easy route to consultant status, and it is recommended that a special diploma should not be established.An adequate background of general medicine is essential for the diagnosis and treatment of the chronic rheumatic diseases.In addition, however, some special knowledge of orthopaedics, physical medicine, and endocrinology is necessary.
TUMORS OF THE HEART.
Journal: JAMA (1900)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Dermatologic Radiotherapy
Authors: Philip C. Anderson
Journal: JAMA (1977)

Using many well-conceived diagrams and a text of uncommon simplicity, the authors are able to teach even the most stubborn physician the basic physics concerned with therapeutic x-ray. In the first 70 pages of the book, the "minimum-you-need-toknow" is explained well, and the physician then should be able to explain these matters admirably to his patients. The last 70 pages emphasize the use of low voltage x-ray to treat diseases of the skin or subcutaneous tissues. The discussion is wholly appropriate for family physicians, general or plastic surgeons, ophthalmologists and otolaryngologists, as well as dermatologists. This pleasant book includes mathematical explanations and deals with concepts such as scattering, attenuation, quantum energy, and wave mechanics—all without baffling the reader. Properly, the authors emphasize the practical conditions of treatment, modern dosimetry, and tissue effects. They compare the various x-ray machines and other methods of radiation. Because this is a brief text, we
Carcinoma of the prostate presenting as a mass in the neck
Authors: M. M. Warren
Journal: JAMA (1970)

In five patients with metastatic carcinoma of the prostate involving the supraclavicular lymph nodes, the initial complaint was a mass in the neck. Rectal examination of the prostate in a patient with supraclavicular nodal involvement is important, even if pathologic examination of the nodal tissue is not clearly diagnostic of the lesion.
Error in Table and Text
Authors: Lindsay Sceats, Cindy Kin, Kristan Staudenmayer
Journal: JAMA Surgery (2019)

Michael H. Wood, MD; Arthur M. Carlin, MD; Amir A. Ghaferi, MD; Oliver A. Varban, MD; Abdelkader Hawasli, MD; Aaron J. Bonham, MSc; Nancy J. Birkmeyer, PhD; Jonathan F. Finks, MD
Nilay Patel
Authors: D. Cranston
Journal: BMJ (2014)

Vine performance following preveraison shoot trimming is well documented, but the consequences of this treatment later in the season are poorly understood. Here, a four-year study was conducted in a mature vineyard of Sangiovese (clone 12T) grafted onto Kober 5BB rootstock at a spacing of 1 m × 2.8 m (intra- and interrow) to analyze the influence of postveraison shoot trimming on vine growth characteristics, cluster architecture (cluster compactness), and yield from a physiological viewpoint. The treatments consisted of shoot trimming during postveraison in a randomized block design with eight replications (six vines each). Three treatments were imposed when soluble solids reached 15 Brix in August (40 to 45 days before expected harvest): light trimming (14 nodes), severe trimming (10 nodes), and an untrimmed control. Following the treatments, vine growth characteristics, cluster morphology, and fruit quality attributes were measured. Postveraison shoot trimming (especially severe trimming) reduced cluster weight, cluster compactness, productivity, and total yield. Effects on fruit quality included lowering of Brix and pH, with minor effects on titratable acidity, yeast assimilable nitrogen, the anthocyanin profile, and total anthocyanins. These results demonstrated that postveraison shoot trimming can be a valuable production practice by reducing cluster compactness without compromising overall fruit quality in Sangiovese.
In-flight medical emergencies
Authors: J. M. Nicoll
Journal: JAMA (1989)

<h3>To the Editor.—</h3> From the statistics of in-flight deaths reported by Cummins et al,<sup>1</sup>one might infer that the problem is a minor one; however, serious illness that occurs during commercial air travel may be a much larger problem. Some of Cummins' coauthors have claimed that "all airlines... rely on the chance presence of a doctor competent to deal with the more serious emergency."<sup>2</sup>This is not necessarily the case.<sup>1,3</sup> However, as passengers, we have been requested to attend to in-flight medical emergencies on several different occasions. We have found that the crew are only too relieved to shift the responsibility for the patient onto any co-opted physician-passenger. On a recent intercontinental flight both a psychiatrist and one of the authors (K.R.E.), an anesthesiologist, responded to the call for help. The psychiatrist, who arrived first, pronounced that the patient was "just fine." The anesthesiologist found that this
A Shedding of Light
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal